Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025The Journal of V N Karazin Kharkiv National University series MedicineOpen Access

The role of serum catestatin in lipid metabolism disorders in patients with coronary artery disease and chronic heart failure depending on concomitant metabolic pathology

View Full Paper
Ask AI
Bookmark
Share

Authors

KBK. M. BorovykПКПавло Григорович КравчунOKO. I. Kadykova

Discussion

Loading...

Member takes

Overview

Research demonstrates lipid profile disorders and catestatin levels in patients with coronary artery disease and chronic heart failure, indicating potential therapeutic strategies.

Key Points

  • Patients with chronic heart failure and coronary artery disease showed significant lipid profile disorders.
  • Group with type 2 diabetes and obesity displayed the lowest catestatin levels, indicating metabolic disturbance.
  • The study observed significant correlations between catestatin levels and various lipid metabolism parameters.
  • Findings emphasize the need for comprehensive treatment approaches for patients suffering from these conditions.

Cite This Study

Borovyk et al. (2025) studied this question.

synapsesocial.com/papers/68c23e94b210217d64792ea8https://doi.org/10.26565/2313-6693-2025-54-04
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Modern strategies for lipid-lowering therapy in patients with ischaemic heart failure and concomitant metabolic pathology2025
  2. 2Association of LDL Cholesterol and hs-CRP with Subtypes of Heart Failure in Type 2 Diabetes Mellitus Patients: A Cross-sectional Study2025
  3. 3High‐intensity statin therapy is associated with reduced coronary inflammation on <scp>CT</scp> in patients with type 2 diabetes mellitus2025 · 3 citations
  4. 4The Impact of Metabolic Control on Cardiovascular Outcomes in Patients with Type 2 Diabetes and Chronic Multivessel Coronary Artery Disease: A Cohort Study2025
  5. 5Analysis of Methods for Normalizing Lipid Profile and Blood Pressure in Patients with Chronic Coronary Syndromes2025